Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Boston Scientific Corporation (BSX) vs Paychex, Inc. (PAYX) Price & Performance

Boston Scientific CorporationTrade
Paychex, Inc.Trade

Price performance (Past 24H)

Key statistics

Boston Scientific Corporation vs Paychex, Inc. — how do they compare? Boston Scientific Corporation trades at $51 (market cap $71.46B), while Paychex, Inc. trades at $120.92 (market cap $43.10B). The key difference: Boston Scientific Corporation is the larger of the two by market cap, and Paychex, Inc. pays a 3.93% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.

BSXPAYX
Market Cap
$71.46B$43.10B
Sector
HealthIndustrials
52-Week High
$108.14$140.81
52-Week Low
$42.63$85.57
Enterprise Value
$83.55B$46.59B
Dividend Yield
3.93%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Boston Scientific Corporation

No Aura AI signal available yet.

Paychex, Inc.

Paychex (PAYX) trades at $120.04, down slightly by 0.07% on the day, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.32 exceeding the $1.31 estimate. Revenue grew to $5.57 billion in 2025, though net income margin dipped to 27.03%. Recent news highlights expansion of its WISE platform and steady small business employment trends, supporting growth prospects.

The outlook remains positive given consistent earnings outperformance and strategic initiatives, but risks include elevated valuation ratios and potential economic sensitivity. Analyst consensus is mixed with a hold-heavy rating, and the current price sits above the $114.50 target, suggesting limited near-term upside. Dividend payments provide income support, yet investors should weigh growth against premium multiples.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Read more on BSX

About Paychex, Inc.

Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.

Read more on PAYX